Covid-19 pandemic, hopefully, teaches Indonesia an important lesson, that it should grow more domestic production of pharmaceutical products to support its 280 million population. Relying too much on import would cost lives because disruption in logistic operation during the pandemic’s restrictions in major producing countries hurt Indonesians.To subscribe please click here
